Drug Screening of Flavonoids as Potential VEGF Inhibitors Through Computational Docking and Cell Models

Vascular endothelial growth factor (VEGF), also known as VEGF-A, has been linked to various diseases, such as wet age-related macular degeneration (wAMD) and cancer. Even though there are VEGF inhibitors that are currently commercially available in clinical applications, severe adverse effects have...

Full description

Saved in:
Bibliographic Details
Main Authors: Shengying Lin, Roy Wai-Lun Tang, Yutong Ye, Chenxi Xia, Jiahui Wu, Ran Duan, Ka-Wing Leung, Tina Ting-Xia Dong, Karl Wah-Keung Tsim
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/30/2/257
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832587839073681408
author Shengying Lin
Roy Wai-Lun Tang
Yutong Ye
Chenxi Xia
Jiahui Wu
Ran Duan
Ka-Wing Leung
Tina Ting-Xia Dong
Karl Wah-Keung Tsim
author_facet Shengying Lin
Roy Wai-Lun Tang
Yutong Ye
Chenxi Xia
Jiahui Wu
Ran Duan
Ka-Wing Leung
Tina Ting-Xia Dong
Karl Wah-Keung Tsim
author_sort Shengying Lin
collection DOAJ
description Vascular endothelial growth factor (VEGF), also known as VEGF-A, has been linked to various diseases, such as wet age-related macular degeneration (wAMD) and cancer. Even though there are VEGF inhibitors that are currently commercially available in clinical applications, severe adverse effects have been associated with these treatments. There is still a need to develop novel VEGF-based therapeutics against these VEGF-related diseases. Here, we established a series of VEGF-based computational docking analyses and cell models, such as a wound healing assay in HaCaT cells and an evaluation of NF-κB performance in macrophages, to screen a large library of flavonoid-type phytochemicals. Three flavonoids, namely, farrerol, ononin and (−)-epicatechin, were shown to express binding affinities to VEGF protein and inhibit VEGF-mediated biological activities. The investigation evidently suggested that the three flavonoids above could be considered potential anti-VEGF agents for the following drug development against VEGF-mediated diseases.
format Article
id doaj-art-30496987ef56478a822cde016c6ad1bf
institution Kabale University
issn 1420-3049
language English
publishDate 2025-01-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj-art-30496987ef56478a822cde016c6ad1bf2025-01-24T13:43:17ZengMDPI AGMolecules1420-30492025-01-0130225710.3390/molecules30020257Drug Screening of Flavonoids as Potential VEGF Inhibitors Through Computational Docking and Cell ModelsShengying Lin0Roy Wai-Lun Tang1Yutong Ye2Chenxi Xia3Jiahui Wu4Ran Duan5Ka-Wing Leung6Tina Ting-Xia Dong7Karl Wah-Keung Tsim8Center for Chinese Medicine, Division of Life Science, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, ChinaCenter for Chinese Medicine, Division of Life Science, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, ChinaCenter for Chinese Medicine, Division of Life Science, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, ChinaCenter for Chinese Medicine, Division of Life Science, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, ChinaCenter for Chinese Medicine, Division of Life Science, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, ChinaCenter for Chinese Medicine, Division of Life Science, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, ChinaCenter for Chinese Medicine, Division of Life Science, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, ChinaCenter for Chinese Medicine, Division of Life Science, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, ChinaCenter for Chinese Medicine, Division of Life Science, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, ChinaVascular endothelial growth factor (VEGF), also known as VEGF-A, has been linked to various diseases, such as wet age-related macular degeneration (wAMD) and cancer. Even though there are VEGF inhibitors that are currently commercially available in clinical applications, severe adverse effects have been associated with these treatments. There is still a need to develop novel VEGF-based therapeutics against these VEGF-related diseases. Here, we established a series of VEGF-based computational docking analyses and cell models, such as a wound healing assay in HaCaT cells and an evaluation of NF-κB performance in macrophages, to screen a large library of flavonoid-type phytochemicals. Three flavonoids, namely, farrerol, ononin and (−)-epicatechin, were shown to express binding affinities to VEGF protein and inhibit VEGF-mediated biological activities. The investigation evidently suggested that the three flavonoids above could be considered potential anti-VEGF agents for the following drug development against VEGF-mediated diseases.https://www.mdpi.com/1420-3049/30/2/257computational dockingdrug screeningflavonoidsVEGF inhibitorangiogenesis
spellingShingle Shengying Lin
Roy Wai-Lun Tang
Yutong Ye
Chenxi Xia
Jiahui Wu
Ran Duan
Ka-Wing Leung
Tina Ting-Xia Dong
Karl Wah-Keung Tsim
Drug Screening of Flavonoids as Potential VEGF Inhibitors Through Computational Docking and Cell Models
Molecules
computational docking
drug screening
flavonoids
VEGF inhibitor
angiogenesis
title Drug Screening of Flavonoids as Potential VEGF Inhibitors Through Computational Docking and Cell Models
title_full Drug Screening of Flavonoids as Potential VEGF Inhibitors Through Computational Docking and Cell Models
title_fullStr Drug Screening of Flavonoids as Potential VEGF Inhibitors Through Computational Docking and Cell Models
title_full_unstemmed Drug Screening of Flavonoids as Potential VEGF Inhibitors Through Computational Docking and Cell Models
title_short Drug Screening of Flavonoids as Potential VEGF Inhibitors Through Computational Docking and Cell Models
title_sort drug screening of flavonoids as potential vegf inhibitors through computational docking and cell models
topic computational docking
drug screening
flavonoids
VEGF inhibitor
angiogenesis
url https://www.mdpi.com/1420-3049/30/2/257
work_keys_str_mv AT shengyinglin drugscreeningofflavonoidsaspotentialvegfinhibitorsthroughcomputationaldockingandcellmodels
AT roywailuntang drugscreeningofflavonoidsaspotentialvegfinhibitorsthroughcomputationaldockingandcellmodels
AT yutongye drugscreeningofflavonoidsaspotentialvegfinhibitorsthroughcomputationaldockingandcellmodels
AT chenxixia drugscreeningofflavonoidsaspotentialvegfinhibitorsthroughcomputationaldockingandcellmodels
AT jiahuiwu drugscreeningofflavonoidsaspotentialvegfinhibitorsthroughcomputationaldockingandcellmodels
AT randuan drugscreeningofflavonoidsaspotentialvegfinhibitorsthroughcomputationaldockingandcellmodels
AT kawingleung drugscreeningofflavonoidsaspotentialvegfinhibitorsthroughcomputationaldockingandcellmodels
AT tinatingxiadong drugscreeningofflavonoidsaspotentialvegfinhibitorsthroughcomputationaldockingandcellmodels
AT karlwahkeungtsim drugscreeningofflavonoidsaspotentialvegfinhibitorsthroughcomputationaldockingandcellmodels